Back
LeMaitre Vascular, Inc. 10K Form
Buy
62
LMAT
LeMaitre Vascular, Inc.
Last Price:
$106.81
Seasonality Move:
3.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | LMAT/LeMaitre Vascular, Inc. Quarterly |
| 2023-11-07 | 10Q | LMAT/LeMaitre Vascular, Inc. Quarterly |
| 2023-08-08 | 10Q | LMAT/LeMaitre Vascular, Inc. Quarterly |
| 2023-05-09 | 10Q | LMAT/LeMaitre Vascular, Inc. Quarterly |
| 2022-11-08 | 10Q | LMAT/LeMaitre Vascular, Inc. Quarterly |
| 2022-08-05 | 10Q | LMAT/LeMaitre Vascular, Inc. Quarterly |
Receive LMAT News And Ratings
See the #1 stock for the next 7 days that we like better than LMAT
LMAT Financial Statistics
Sales & Book Value
| Annual Sales: | $219.9M |
|---|---|
| Cash Flow: | $26.5M |
| Price / Cash Flow: | 32.11 |
| Annual Sales: | $16.71 |
| Price / Book: | 6.81 |
Profitability
| EPS (TTM): | 2.51550 |
|---|---|
| Net Income (TTM): | $57.7M |
| Gross Margin: | $145.1M |
| Return on Equity: | 15.86% |
| Return on Assets: | 9.96% |
LeMaitre Vascular, Inc. Earnings Forecast
Key LeMaitre Vascular, Inc. Financial Ratios
-
The Gross Profit Margin over the past 24 years for LMAT is 66.00%.
-
The Selling, General & Administrative Expenses for LMAT have been equal to 37.75% of Gross Profit Margin.
-
The Research & Development expenses have been 7.12% of Revenue.
-
The Interest Expense is 0.47% of Operating Income.
-
The Net Earning history of LMAT is 20.03% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 15 years.
LeMaitre Vascular, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | LMAT |
| CUSIP: | 525558 |
| Website: | lemaitre.com |
Debt
| Debt-to-Equity Ratio: | 0.47 |
|---|---|
| Current Ratio: | 12.89 |
| Quick Ratio: | 10.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 45.12 |
|---|---|
| Forward P/E Ratio: | 36.39 |
LMAT Technical Analysis vs Fundamental Analysis
Buy
62
LeMaitre Vascular, Inc. (LMAT)
is a Buy
Is LeMaitre Vascular, Inc. a Buy or a Sell?
-
LeMaitre Vascular, Inc. stock is rated a BuyThe current LeMaitre Vascular, Inc. [LMAT] share price is $113.69. The Score for LMAT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.